KR-26556
KR-26556 is a sulfonamide type hepatitis B virus (HBV) capsid assembly regulator. KR-26556 exhibits anti-HBV activity with an EC50 of 0.04 μM. KR-26556 has favorable safety characteristics. KR-26556 can be used for research on chronic hepatitis B.
For research use only. We do not sell to patients.
- CAS No.: 2411762-66-6
- Formula: C18H17F4N3O4S
- Molecular Weight:447.40
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HEK293 | IC50 |
8.78 μM
Compound: 11; KR-26556
|
Inhibition of human ERG expressed in human HEK293 cells by patch clamp assay
Inhibition of human ERG expressed in human HEK293 cells by patch clamp assay
|
[PMID: 32071684] |
| HepG2 2.2.15 | CC50 |
19.7 μM
Compound: 15; KR-26556
|
Cytotoxicity against human HepG2 2.2.15 cells assessed as reduction in cell viability incubated for 5 days by MTT assay
Cytotoxicity against human HepG2 2.2.15 cells assessed as reduction in cell viability incubated for 5 days by MTT assay
|
[PMID: 33603970] |
Chemical Information
-
CAS No. 2411762-66-6
-
Molecular Weight 447.40
-
Formula C18H17F4N3O4S
-
SMILES
O=C(NC1=CC(F)=C(F)C(F)=C1)C2=CC(S(=O)(N3CCC(O)CC3)=O)=C(F)C=C2N
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)